Cresset Asset Management, LLC Sarepta Therapeutics, Inc. Transaction History

Cresset Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $14,233 - $22,417	-188 Reduced 5.09%	3,505 $387,000
Q2 2022 Aug 15, 2022	SELL	$62.69 - $88.44 $16,048 - $22,640	-256 Reduced 6.48%	3,693 $275,000
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $79,190 - $113,386	-1,254 Reduced 24.1%	3,949 $309,000
Q4 2021 Feb 10, 2022	BUY	$77.28 - $99.42 $161,051 - $207,191	2,084 Added 66.82%	5,203 $469,000
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $205,760 - $288,445	3,119 New	3,119 $288,000
Q2 2019 Aug 12, 2019	SELL	$112.21 - $151.95 $561 - $759	-5 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $533 - $758	5 New	5 $1,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.